Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43 by Siziopikou, Kalliopi P., Anderson, Stewart J., Cobleigh, Melody A., Julian, Thomas B., Arthur, Douglas W., Zheng, Ping, Mamounas, Eleftherios P., Pajon, Eduardo R., Behrens, Robert J., Eakle, Janice F., Leasure, Nick C., Atkins, James N., Polikoff, Jonathan A., Seay, Thomas E., McCaskill-Stevens, Worta J., Rabinovitch, Rachel, Costantino, Joseph P., Wolmark, Norman

Get full text

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial by Allegra, Carmen J, Yothers, Greg, O'Connell, Michael J, Beart, Robert W, Wozniak, Timothy F, Pitot, Henry C, Shields, Anthony F, Landry, Jerome C, Ryan, David P, Arora, Amit, Evans, Lisa S, Bahary, Nathan, Soori, Gamini, Eakle, Janice F, Robertson, John M, Moore, Jr, Dennis F, Mullane, Michael R, Marchello, Benjamin T, Ward, Patrick J, Sharif, Saima, Roh, Mark S, Wolmark, Norman

Get full text

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women With Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase II Trial by Yardley, Denise A., Ward, Patrick J., Daniel, Brooke R., Eakle, Janice F., Lamar, Ruth E., Lane, Cassie M., Hainsworth, John D.

Get full text

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer by Spigel, David R, Greco, F. Anthony, Rubin, Mark S, Shipley, Dianna, Thompson, Dana S, Lubiner, Eric T, Eakle, Janice F, Quinn, Raven, Burris, Howard A, Hainsworth, John D

Get full text

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute by Yardley, Denise A, Zubkus, John D, Eakle, Janice F, Bechhold, Rebecca G, Finney, Lindsey, Daniel, Davey, Daniel, Brooke, Hainsworth, John D

Get full text

Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial by Allegra, Carmen J, Yothers, Greg, O'Connell, Michael J, Beart, Robert W, Wozniak, Timothy F, Pitot, Henry C, Shields, Anthony F, Landry, Jerome C, Ryan, David P, Arora, Amit, Evans, Lisa S, Bahary, Nathan, Soori, Gamini, Eakle, Janice F, Robertson, John M, Moore, Dennis F, Mullane, Michael R, Marchello, Benjamin T, Ward, Patrick J, Sharif, Saima, Roh, Mark S, Wolmark, Norman

Get full text

Panitumumab, Gemcitabine, and Carboplatin as Treatment for Women with Metastatic Triple-Negative Breast Cancer: A Sarah Cannon Research Institute Phase 2 Trial by Yardley, Denise A., MD, Ward, Patrick J., MD, Daniel, Brooke R., MD, Eakle, Janice F., MD, Lamar, Ruth E., MD, Lane, Cassie M., MS, Hainsworth, John D., MD

Get full text

Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure... by Landovitz, Raphael J, Tao, Li, Yang, Juan, de Boer, Melanie, Carter, Christoph, Das, Moupali, Baeten, Jared M, Liu, Albert, Hoover, Karen W, Celum, Connie, Grinsztejn, Beatriz, Morris, Sheldon, Wheeler, Darrell P, Mayer, Kenneth H, Golub, Sarit A, Bekker, Linda-Gail, Diabaté, Souleymane, Hoornenborg, Elske, Myers, Janet, Leech, Ashley A, McCormack, Sheena, Chan, Philip A, Sweat, Michael, Matthews, Lynn T, Grant, Robert

Get full text